BVDV Tag

Diagnosis, vaccination, and biosecurity to control BVDV

“We must take a three-pronged approach to address the problem: diagnosis, prevention through vaccination and biosecurity of facilities”. Said by Dr. Paul Walz, of the College of Veterinary Medicine at Auburn University, Alabama, in the United States, during the 3rd International Congress of Bovine Viral Diarrhea Virus (BVDV) organized…

3rd International Congress on Bovine Viral Diarrhea Virus

At this year’s event, which will be held under the theme “Impact and Management of BVD Virus in Cattle,” international experts will discuss strategies to control this disease and mitigate its impact on livestock. Next August 28 at 6:00 PM, the 3rd International Congress on Bovine Viral Diarrhea…

Vedevax Block Vaccine finalist for the Empretec Award

The world’s first targeted vaccine against the Bovine Viral Diarrhea Virus (BVDV), developed by Bioinnovo, was one of 4 finalists in its category among around 1,000 projects submitted at the 13th edition of the Pioneering Solutions Contest from Banco Nación, aimed at SMEs and enterprises….

BVDV, immunosuppression, and its impact on cattle herds

Knowledge about the impact of this virus on production and control measures to mitigate its effect on the herd was disseminated at the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), convened by Bioinnovo and INTA. The Second International BVDV Congress, held virtually by…

Second International Congress on Bovine Viral Diarrhea

In August, Bioinnovo will host the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), which will be held remotely. Bioinnovo, the public-private company made up of Vetanco and INTA, will host the Second International Congress on BVDV, which will be held online on Monday,…

Innovation in Veterinary Vaccines

Bioinnovo has participated in 2021 ISV Annual Virtual Congress by sharing experiences in the development of innovative veterinary vaccines to fight against several diseases, and by introducing the successful case of Vedevax Block, the first subunit recombinant vaccine in the world that has been approved…

Second day of the International Congress on BVDV

The second day of the First International Congress on Bovine Viral Diarrhea Virus (BVDV) was held last Monday, August 2, and dealt with the different available vaccines and vaccination strategies to fight against this virus, responsible for millions of dollars in losses to national farms….

First day of the BVDV International Congress

On Monday, July 12 the International Congress of Bovine Viral Diarrhea Virus (BVDV) was initiated addressing the problems raised by the disease in cattle as well as its enormous economic losses and alternatives for its control. Bioinnovo, the public-private company formed by Vetanco and INTA, has organized the First International Congress…

Bioinnovo at the 2021 ASAS-CSAS-SSASAS Annual Meeting & Trade Show

Organized by the American Society of Animal Science (ASAS), the 2021 ASAS-CSAS-SSASAS Annual Meeting & Trade Show will be held on July 14-17 in a hybrid modality. During the event, Bioinnovo representatives will present the studies conducted with Vedevax BLOCK, the first targeted subunit vaccine against…

First International Congress on Bovine Viral Diarrhea Virus

On Monday, July 12, and August 2, 2021, Bioinnovo organizes the First International Congress of Bovine Viral Diarrhea Virus (BVDV), which will be held virtually. Bioinnovo, a public-private partnership between Vetanco and INTA, is the organizer of the First International Congress of Bovine Viral Diarrhea Virus, to be…